Dear Tamar, this is a calendar invitation for a conversation with our Deloitte team in regards to a Post-COVID advisory assessment we are conducting for GoG, as part of the USAID Economic Governance Program. The call will be led by our Deloitte sectoral policy specialist, Jess Majno.

9:00pm Tbilisi (1:00pm Washington)

Thanks and Best Regards,

Luis F. Paniagua

Deloitte Consulting LLP

1919 N. Lynn Street, Arlington, VA 22209

Tel/Direct: +1 571 814 7884 | Mobile: +1 703 853 9422

lupaniagua@deloitte.com <mailto:lupaniagua@deloitte.com> | www.deloitte.com <http://www.deloitte.com>

Please consider the environment before printing.

Join Meeting <https://deloitte.zoom.us/j/96328396110?pwd=S1o4Y0JtSUt1QW9aME5yei8venhDQT09> Password: 242923 Phone one-tap: US: +19294362866,,96328396110# <tel:+19294362866,,96328396110> or +16699006833,,96328396110# <tel:+16699006833,,96328396110> Join by Telephone Dial: US: +1 929 436 2866 or +1 669 900 6833 Meeting ID: 963 2839 6110 Password: 242923 International numbers <https://deloitte.zoom.us/u/ab8dxj3RtZ> Zoom technology includes options for recording a meeting. If a meeting is being recorded, an audio and/or visual warning will be provided when you join a recorded meeting. A warning will also be provided if recording commences after you have joined the meeting. If you continue to participate in the meeting following these warnings, your participation will serve as your express consent to such recording.

This message (including any attachments) contains confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this message and any disclosure, copying, or distribution of this message, or the taking of any action based on it, by you is strictly prohibited.

Deloitte refers to a Deloitte member firm, one of its related entities, or Deloitte Touche Tohmatsu Limited ("DTTL"). Each Deloitte member firm is a separate legal entity and a member of DTTL. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.

v.E.1